CHG-2023-0242

Container Closure Change for Verasenib. Analytical Method Change for Verasenib — major revision. Impacts 4 markets and 4 variations.

Change Number
CHG-2023-0242
Type
Container Closure Change
Product
Verasenib
Status
Active
Owner
Lieselotte van der Berg
Initiated
2022-10-28
Description

Analytical Method Change for Verasenib — major revision

Impacted Markets (4)
US — United StatesCH — SwitzerlandTR — TurkeyAT — Austria
Impacted Modules
4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved